0000059478-17-000028.txt : 20170131 0000059478-17-000028.hdr.sgml : 20170131 20170131175102 ACCESSION NUMBER: 0000059478-17-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170127 FILED AS OF DATE: 20170131 DATE AS OF CHANGE: 20170131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conterno Enrique A CENTRAL INDEX KEY: 0001476151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 17562358 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER CITY: INDIANAPOLIS STATE: IN ZIP: 46285 4 1 wf-form4_148590304851291.xml FORM 4 X0306 4 2017-01-27 0 0000059478 LILLY ELI & CO LLY 0001476151 Conterno Enrique A LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 1 0 0 Sr. VP & Pres., Lilly Diabetes Common Stock 2017-01-27 4 A 0 20211 75.38 A 133783 D Common Stock 4926 I 401(k) Restricted Stock Unit 2017-01-27 4 A 0 21326 0 A 2018-02-01 2018-02-01 Common Stock 21326.0 21326 D Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Tiffany R. Benjamin for Enrique Conterno, authorization on file 2017-01-31 EX-24 2 conternopoa.htm CONTERNO_POA




Enrique A. Conterno
Lilly Corporate Center
Indianapolis, Indiana  46285



Securities and Exchange Commission
Washington, D.C.  20549

AuthorizationRegardingReportingForms

I hereby authorize and designate the following persons to sign and file with the Commission on my behalf Forms 3, 4, and 5 (including any amendments thereto) covering my transactions and holdings in the common stock and other equity securities of Eli Lilly and Company as required by Section 16 of the Securities Exchange Act of 1934 and the rules thereunder:

    Michael J. Harrington, Lilly Corporate Center, Indianapolis, Indiana

    Bronwen L. Mantlo, Lilly Corporate Center, Indianapolis, Indiana

    Tiffany R. Benjamin, Lilly Corporate Center, Indianapolis, Indiana

This authorization and designation shall remain in effect until a written revocation is signed by me and provided to the Commission.


Date: July 25, 2016


/s/ Enrique A. Conterno